EXICURE, INC. Prepaid Expense and Other Assets, Current
EXICURE, INC. (XCUR) had Prepaid Expense and Other Assets, Current of $597.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-14
- 2026-06-30: Prepaid Expense and Other Assets, Current $597.00K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $868.00K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $820.00K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $946.00K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $597.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $868.00K 10-Q · filed 2026-05-29 | |
| 2025-12-31 | $820.00K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $946.00K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $711.00K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $713.00K 10-Q · filed 2025-06-27 | |
| 2024-12-31 | $644.00K 10-K · filed 2026-03-25 | |
| 2024-09-30 | $907.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $992.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.10M 10-Q · filed 2024-06-17 | |
| 2023-12-31 | $1.19M 10-K · filed 2025-03-18 | |
| 2023-09-30 | $1.46M 10-Q · filed 2024-05-16 | |
| 2023-06-30 | $1.33M 10-Q/A · filed 2024-06-06 | |
| 2023-03-31 | $1.32M 10-Q/A · filed 2024-06-06 | |
| 2022-12-31 | $1.47M 10-Q/A · filed 2024-06-06 | |
| 2022-09-30 | $1.55M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $2.53M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $2.80M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $4.53M 10-K · filed 2023-03-27 | |
| 2021-09-30 | $3.31M 10-Q · filed 2021-11-19 | |
| 2021-06-30 | $4.59M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $6.55M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $4.23M 10-K · filed 2022-03-25 | |
| 2020-09-30 | $2.68M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $3.59M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $2.91M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $1.96M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $1.34M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.57M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.41M 10-Q · filed 2019-05-08 | |
| 2019-01-01 | $1.36M 10-K · filed 2020-03-10 | $1.35M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.39M 10-K · filed 2021-03-11 | $1.38M 10-K · filed 2019-03-08 |
| 2018-09-30 | $1.85M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $1.62M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $1.90M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $1.84M 10-K/A · filed 2019-09-23 | $912.00K 10-K · filed 2018-03-09 |
| 2017-09-30 | $1.13M 10-Q · filed 2017-11-14 | |
| 2016-12-31 | $403.00K 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |